A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain
Purpose To develop and validate a deep learning algorithm that predicts the final diagnosis
of Alzheimer disease (AD), mild cognitive impairment, or neither at fluorine 18 ( 18 F) …
of Alzheimer disease (AD), mild cognitive impairment, or neither at fluorine 18 ( 18 F) …
[HTML][HTML] Machine learning applications for differentiation of glioma from brain metastasis—a systematic review
…, VL Chiang, A Malhotra, B Scheffler, MS Aboian - Cancers, 2022 - mdpi.com
Simple Summary We present a systematic review of published reports on machine learning (ML)
applications for the differentiation of gliomas from brain metastases by summarizing …
applications for the differentiation of gliomas from brain metastases by summarizing …
Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation
MS Aboian, DA Solomon, E Felton… - American Journal …, 2017 - Am Soc Neuroradiology
… ), 3D fluid-attenuated inversion recovery (TR/TE/TI, 5500/136/2200 ms), T1-weighted (TR/TE,
10/4 ms) without and with and intravenous gadolinium, and axial diffusion-weighted …
10/4 ms) without and with and intravenous gadolinium, and axial diffusion-weighted …
Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy
E Panditharatna, LB Kilburn, MS Aboian… - Clinical Cancer …, 2018 - AACR
… or nonenhancing lesions by an experienced neuro-oncologist (SN Magge) and neuroradiology
fellow (MS Aboian) with guidance from a board-certified neuroradiologist (S. Cha). …
fellow (MS Aboian) with guidance from a board-certified neuroradiologist (S. Cha). …
[HTML][HTML] Machine learning tools for image-based glioma grading and the quality of their reporting: Challenges and opportunities
Simple Summary Despite their prevalence in research, ML tools that can predict glioma
grade from medical images have yet to be incorporated clinically. The reporting quality of ML …
grade from medical images have yet to be incorporated clinically. The reporting quality of ML …
Machine learning in differentiating gliomas from primary CNS lymphomas: a systematic review, reporting quality, and risk of bias assessment
BACKGROUND: Differentiating gliomas and primary CNS lymphoma represents a diagnostic
challenge with important therapeutic ramifications. Biopsy is the preferred method of …
challenge with important therapeutic ramifications. Biopsy is the preferred method of …
124I-MIBG PET/CT to monitor metastatic disease in children with relapsed neuroblastoma
The metaiodobenzylguanidine (MIBG) scan is one of the most sensitive noninvasive lesion
detection modalities for neuroblastoma. Unlike 123 I-MIBG, 124 I-MIBG allows high-…
detection modalities for neuroblastoma. Unlike 123 I-MIBG, 124 I-MIBG allows high-…
3D printed absorber for capturing chemotherapy drugs before they spread through the body
Despite efforts to develop increasingly targeted and personalized cancer therapeutics,
dosing of drugs in cancer chemotherapy is limited by systemic toxic side effects. We have …
dosing of drugs in cancer chemotherapy is limited by systemic toxic side effects. We have …
[HTML][HTML] Drug capture materials based on genomic DNA-functionalized magnetic nanoparticles
… were temporarily isolated using an external magnet so that 100 μL aliquots could be taken,
which were diluted 200× in 2% nitric acid solution and subsequently analyzed by ICP-MS to …
which were diluted 200× in 2% nitric acid solution and subsequently analyzed by ICP-MS to …
Diffusion characteristics of pediatric diffuse midline gliomas with histone H3-K27M mutation using apparent diffusion coefficient histogram analysis
MS Aboian, E Tong, DA Solomon… - American Journal …, 2019 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Diffuse midline gliomas with histone H3 K27M mutation
are biologically aggressive tumors with poor prognosis defined as a new diagnostic entity in …
are biologically aggressive tumors with poor prognosis defined as a new diagnostic entity in …